Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Pharma-Bio Serv (PBSV) over the last 17 years, with Q4 2025 value amounting to $7661.0.

  • Pharma-Bio Serv's Exchange Rate Effect rose 37527.85% to $7661.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $44494.0, marking a year-over-year increase of 35237.66%. This contributed to the annual value of $44494.0 for FY2025, which is 35237.66% up from last year.
  • Per Pharma-Bio Serv's latest filing, its Exchange Rate Effect stood at $7661.0 for Q4 2025, which was up 37527.85% from $4377.0 recorded in Q3 2025.
  • In the past 5 years, Pharma-Bio Serv's Exchange Rate Effect ranged from a high of $90619.0 in Q1 2023 and a low of -$58225.0 during Q4 2023
  • Its 5-year average for Exchange Rate Effect is $1384.8, with a median of -$2641.5 in 2023.
  • In the last 5 years, Pharma-Bio Serv's Exchange Rate Effect crashed by 56895.26% in 2022 and then skyrocketed by 150974.8% in 2023.
  • Over the past 5 years, Pharma-Bio Serv's Exchange Rate Effect (Quarter) stood at -$32169.0 in 2021, then skyrocketed by 32.62% to -$21675.0 in 2022, then crashed by 168.63% to -$58225.0 in 2023, then surged by 95.22% to -$2783.0 in 2024, then soared by 375.28% to $7661.0 in 2025.
  • Its last three reported values are $7661.0 in Q4 2025, $4377.0 for Q3 2025, and $51541.0 during Q2 2025.